Michael P. Dube - VP, Chief Accounting Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Chief Accounting Officer
Issuer Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

Michael P. Dube - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by Michael P. Dube for Intellia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69,527 $868,392 $12.49 01 Mar 2026 Direct

Transactions reported by Michael P. Dube for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.